Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Work Institut Jules Bordet

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Jules Bordet Institute, part of H.U.B., is a state-of-the-art hospital specializing in the diagnosis and treatment of cancer. It is located on the Anderlecht campus, in close proximity to Erasme Hospital.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
34Total Trials
Source: Trial-derived.
10Recruiting Trials
Source: Trial-derived.
19Active Trials
Source: Trial-derived.
11Completed Trials
Source: Trial-derived.
42Unique Conditions
Source: Trial-derived.
47Unique Sponsors

Conditions

Source: Trial-derived. Ovarian Cancer (5)Source: Trial-derived. Colorectal Cancer (3)Source: Trial-derived. Advanced Solid Tumor (2)Source: Trial-derived. Lymphoma, Non-Hodgkin (2)Source: Trial-derived. Non Small Cell Lung Cancer (2)Source: Trial-derived. NSCLC (2)Source: Trial-derived. Advanced Metastatic Castration-resistant Prostate Cancer (1)Source: Trial-derived. Advanced Solid Tumor Cancer (1)

Sponsors

Source: Trial-derived. Bayer (3)Source: Trial-derived. GOG Foundation (3)Source: Trial-derived. Incyte Corporation (3)Source: Trial-derived. Jules Bordet Institute (3)Source: Trial-derived. The Lymphoma Academic Research Organisation (3)Source: Trial-derived. AstraZeneca (2)Source: Trial-derived. Bristol-Myers Squibb (2)Source: Trial-derived. Eli Lilly and Company (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Histology / pathology

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. ESR1 mutation testing
Source: AI-inferred. Electronic patient-reported outcome (ePRO) data collection
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. NTRK gene fusion molecular testing
Source: AI-inferred. Tumor Treating Fields device therapy delivery
Source: AI-inferred. Tumour cyclin E1 expression testing